The total return over the past 12 months is +34.22% vs. +20.58% for the S&P 500. So far it's up -5.46% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +34.22% | +14.62% | +0.22% | +13.76% | N/A | N/A |
| Total Return CAGR | +34.22% | +14.62% | +0.22% | +13.76% | N/A | N/A |
| Revenue CAGR | +19.74% | +42.05% | +27.65% | +18.92% | +16.74% | N/A |
| Net Income CAGR | +50.14% | +37.86% | +23.81% | +16.34% | +16.49% | N/A |
| EPS CAGR | +51.53% | +28.17% | +30.79% | +12.83% | +11.77% | N/A |
| Free Cash Flow CAGR | +45.06% | +83.69% | +29.93% | +21.58% | +16.58% | N/A |
| Operating Cash Flow CAGR | +36.05% | +70.00% | +28.87% | +19.59% | +17.02% | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Globus Medical, Inc. (GMED)
| Year | Start price | End price | GMED Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $87.31 | $82.54 | (5.46%) | +13.68% | (19.14%) |
| 2025 | $82.71 | $87.31 | +5.56% | +17.72% | (12.16%) |
| 2024 | $53.29 | $82.71 | +55.21% | +24.89% | +30.32% |
| 2023 | $74.27 | $53.29 | (28.25%) | +26.19% | (54.44%) |
| 2022 | $72.20 | $74.27 | +2.87% | (18.17%) | +21.04% |
| 2021 | $65.22 | $72.20 | +10.70% | +28.74% | (18.04%) |
| 2020 | $58.88 | $65.22 | +10.77% | +18.37% | (7.60%) |
| 2019 | $43.28 | $58.88 | +36.04% | +31.22% | +4.82% |
| 2018 | $41.10 | $43.28 | +5.30% | (4.56%) | +9.86% |
| 2017 | $24.81 | $41.10 | +65.66% | +21.70% | +43.96% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
